GemVax & KAEL Says Largest Shareholder Extends Two Share-Backed Loans to February 2027

PUBT · 2d ago
GemVax & KAEL Says Largest Shareholder Extends Two Share-Backed Loans to February 2027
  • GemVax & KAEL issued a correction dated Nov. 16, 2026, extending two share-backed loan agreements involving largest shareholder Gem & Company.
  • Collateral periods for Sangsangin Plus Savings Bank and Sangsangin Savings Bank now run from Nov. 16, 2026, through Feb. 14, 2027.
  • The two agreements pledge 2,030,000 shares, with a combined collateral amount of KRW 17.9 billion.
  • Total pledged shares across 11 agreements stand at 5,429,489, securing borrowings of KRW 44.67 billion.
  • Full collateral enforcement would reduce Gem & Company's stake from 11.95% to 0.01%, leaving it with 3,643 shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GemVax & KAEL Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261116902404), on November 16, 2026, and is solely responsible for the information contained therein.